Kyverna Therapeutics, Inc. KYTX Book value per share

Book value per share at other companies

Gilead SciencesGILD

$9.52-39.3%

Climb Bio, Inc.CLYM

$2.17-24.3%

Artiva Biotherapeutics, Inc.ARTV

$8.82+44.2%

Iovance Biotherapeutics, Inc.IOVA

$1.64-21.7%

Allogene TherapeuticsALLO

$1.16-35.1%

Vor BiopharmaVOR

-$3.50-133%

FAQ

What is Kyverna Therapeutics, Inc.'s book value per share?

Kyverna Therapeutics, Inc. (KYTX) reported book value per share of $3.24 in Q1 2026.

How has Kyverna Therapeutics, Inc.'s book value per share changed year-over-year?

Kyverna Therapeutics, Inc.'s book value per share decreased by 37.6% year-over-year, from $5.18 to $3.24.

What is the long-term trend for Kyverna Therapeutics, Inc.'s book value per share?

Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s book value per share has grown at a -48.1% compound annual growth rate (CAGR), from -$19.51 to $5.25.

What does book value per share mean?

Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.